EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische Übersicht

Testosterone Added to Incretin Therapy in Men With Overweight or Obesity: A Systematic Review of Body Composition Evidence and Gaps

Alejandro Bruna-Mejías iD, Juan José Valenzuela-Fuenzalida, Gustavo Oyanedel, Yasna Jeria-Pizarro, Juan José Cabezas-Salgado, Mathias Orellana-Donoso, Gloria Cifuentes-Suazo, Christopher Blackwood-Espinoza, Juan Francisco Loro-Ferrer

Diabetes, Obesity and Metabolism · 19.11.2026

DOI: 10.1111/dom.71565 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 19.11.2026. Verfasst von Alejandro Bruna-Mejías und 8 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Doctorado en Investigación Aplicada a las Ciencias Sanitarias, Escuela de Doctorado, Universidad de Las Palmas de Gran Canaria (ULPGC), L…. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To characterize body‐composition evidence and muscle and safety gaps for testosterone replacement therapy (TRT) added to incretin treatment in men with overweight or obesity and hypogonadism. Materials and Methods PROSPERO CRD420261489220. Seven databases and two registries were searched through 4 September 2026; citations were checked on 10 September. Eligible studies compared concurrent TRT with a comparable incretin regimen without TRT or examined baseline androgen status longitudinally. The original eight reports underwent independent assessment. Following joint initial screening, 300 randomly sampled units were independently rescreened. ROBINS‐I, RoB 2 and GRADE informed synthesis by design and outcome.

Results

Two reports provided non‐equivalent body‐composition outcomes with very low certainty. Neither established incremental TRT benefit. In a nonrandomized pilot (five men per group), the final DXA lean‐mass difference was +2.70 kg (exploratory, unadjusted 95% CI −1.75 to +7.15); the descriptive difference in changes was +2.1 kg, with change‐score dispersion unavailable. A randomized conference report (266 men across five arms; comparison‐arm sizes unavailable) attributed 26% versus 38% of weight loss to fat‐free mass with versus without TRT. These observations do not corroborate a common biological effect. No usable TRT‐specific strength, function or safety comparisons or eligible baseline‐androgen analyses were identified. Two unclassified registry entries limit completeness.

Conclusions

Available evidence does not establish incremental TRT benefit for body composition or muscle outcomes. Missing functional and safety evidence remains a central gap. TRT solely for lean‐tissue preservation is unsupported.

Schlagwörter

Stichwörter der Autor:innen

GLP‐1 receptor agonistsfat‐free masshypogonadismlean body masssystematic reviewtestosterone replacement therapytirzepatide

Autor:innen und Institutionen

  • Programa de Doctorado en Investigación Aplicada a las Ciencias Sanitarias, Escuela de Doctorado, Universidad de Las Palmas de Gran Canaria (ULPGC), Las Palmas de Gran Canaria, Spain.
  • Escuela de Medicina, Facultad de Medicina, Universidad Andrés Bello, Viña del Mar, Chile.
  • Department of Chemical and Biological Sciences, Faculty of Health Sciences, Universidad Bernardo O'Higgins, Santiago, Chile.
  • Faculty of Health and Social Sciences, Universidad de Las Américas, Santiago, Chile.
  • Faculty of Health Sciences, Universidad Autónoma de Chile, Santiago, Chile.
  • Facultad de Medicina, Universidad Católica del Maule, Talca, Región del Maule, Chile.

ORCID-Profile: Alejandro Bruna-Mejías

Zitieren

APA

Bruna-Mejías, A., Valenzuela-Fuenzalida, J. J., Oyanedel, G., Jeria-Pizarro, Y., Cabezas-Salgado, J. J., Orellana-Donoso, M., Cifuentes-Suazo, G., Blackwood-Espinoza, C., & Loro-Ferrer, J. F. (2026). Testosterone Added to Incretin Therapy in Men With Overweight or Obesity: A Systematic Review of Body Composition Evidence and Gaps. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71565

Vancouver

Bruna-Mejías A, Valenzuela-Fuenzalida JJ, Oyanedel G, Jeria-Pizarro Y, Cabezas-Salgado JJ, Orellana-Donoso M, et al. Testosterone Added to Incretin Therapy in Men With Overweight or Obesity: A Systematic Review of Body Composition Evidence and Gaps. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71565

BibTeX
@article{BrunaMejas2026,
  author = {Bruna-Mejías, Alejandro and Valenzuela-Fuenzalida, Juan José and Oyanedel, Gustavo and Jeria-Pizarro, Yasna and Cabezas-Salgado, Juan José and Orellana-Donoso, Mathias and Cifuentes-Suazo, Gloria and Blackwood-Espinoza, Christopher and Loro-Ferrer, Juan Francisco},
  title = {Testosterone Added to Incretin Therapy in Men With Overweight or Obesity: A Systematic Review of Body Composition Evidence and Gaps},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.71565}
}
Kostenlos starten →